# Cooperman Barnabas Medical Center Inc – FDA Inspection, Apr 29, 2013

Source: https://www.keypedia.com/records/fda_inspections/cooperman-barnabas-medical-center-inc/abb068d9-bea2-4c9d-ae62-7ad1173a2f4b
Source feed: FDA_Inspections

> FDA inspection 829353 of Cooperman Barnabas Medical Center Inc, April 29, 2013. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 606. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 829353
- Company Name: Cooperman Barnabas Medical Center Inc
- Inspection Date: 2013-04-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1271693 - 2025-06-02
- FDA Inspection 1203599 - 2023-04-20
- FDA Inspection 1102095 - 2019-09-12
- FDA Inspection 1013996 - 2017-05-11
- [FDA Inspection 903748 - 2014-11-07](https://www.keypedia.com/records/fda_inspections/cooperman-barnabas-medical-center-inc/32384c8f-f86a-47c9-b9be-d4cc2a3bf677)

Company: https://www.keypedia.com/companies/cooperman-barnabas-medical-center-inc/ef493ab0-370a-4332-9280-ea8fe212cefa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d